Hereditary angioedema (hae) – pipeline review, h2 2012
1 like252 views
The document discusses a report on the pipeline of treatments for Hereditary Angioedema (HAE), including 82 pages on products in development from discovery to registration, with details on companies and universities involved, 20% discounts on reports over $1000, and contact information for sample reports or questions.
1 of 8
Download to read offline
Ad
Recommended
Blepharitis – pipeline review, h1 2012
Blepharitis – pipeline review, h1 2012Rose088The document announces the availability of a market research report on the blepharitis therapeutic pipeline from Global Markets Direct. The report provides an overview of products under development for blepharitis by stage of development, company, and molecule type. It also profiles key companies involved in developing therapeutics for blepharitis and analyzes the pipeline based on monotherapy, administration route, and molecule type. Sample pages of the report can be requested by email.
Keratitis – pipeline review, h1 2012
Keratitis – pipeline review, h1 2012Rose088The document announces the availability of a market research report on the pipeline of treatments for Keratitis from H1 2012. The report provides an overview of therapeutic developments for Keratitis, including both pharmaceutical and university projects at different stages of development. It also profiles companies involved in developing treatments for Keratitis and assesses the pipeline based on factors like route of administration and molecule type. Sample pages of the report can be requested by email.
Amyloidosis – pipeline review, h2 2012
Amyloidosis – pipeline review, h2 2012Rose088This document summarizes a market research report on the pipeline of therapies for amyloidosis. The report provides an overview of therapeutic candidates in development for amyloidosis, including their current stage of development. It analyzes pipeline products by company and university, and profiles major companies involved in developing treatments for this condition, such as GlaxoSmithKline, Isis Pharmaceuticals, and Alnylam Pharmaceuticals. Sample pages of the report can be requested by email for review.
Hypercalcemia – pipeline review, h1 2012
Hypercalcemia – pipeline review, h1 2012Rose088The document summarizes a market research report on the pipeline of treatments for hypercalcemia. The report provides an overview of therapeutic developments for hypercalcemia, including late-stage and discontinued projects. It reviews key players involved in developing treatments and provides a snapshot of the global landscape, including products in development by stage and therapeutic approach. Sample pages of the full report can be requested from the publisher.
Epithelial ovarian cancer – pipeline review, h2 2012
Epithelial ovarian cancer – pipeline review, h2 2012Rose088The document summarizes a market research report from Global Markets Direct titled "Epithelial Ovarian Cancer – Pipeline Review, H2 2012". The report provides an overview of the current therapeutic pipeline for epithelial ovarian cancer, including information on late stage projects, companies involved in development, and assessment of products by factors such as molecule type and administration route. It also lists key report sections such as executive summary, pipeline analysis, company profiles, and individual drug profiles.
Refractory multiple myeloma – pipeline review, h2 2012
Refractory multiple myeloma – pipeline review, h2 2012Rose088The document summarizes a market research report from Global Markets Direct titled "Refractory Multiple Myeloma - Pipeline Review, H2 2012". The report provides an overview of the therapeutic pipeline for refractory multiple myeloma, including late-stage and discontinued projects. It reviews key players and their development of treatments, which are organized by stage of development. Tables of contents and figures are also included.
Amnesia – pipeline review, h1 2012
Amnesia – pipeline review, h1 2012Rose088The document summarizes a market research report on the pipeline of treatments for amnesia in the first half of 2012, including potential new drugs and therapies in development by companies and universities, with the most advanced in mid-stage clinical trials. It provides an overview of the therapeutic landscape for amnesia and profiles of several candidate drugs, as well as tables of contents and links to related reports.
Congestive heart failure (heart failure) – pipeline
Congestive heart failure (heart failure) – pipelineRose088The document summarizes a report on the global pipeline of treatments for congestive heart failure (CHF) in the second half of 2012. The 290-page report provides an overview of CHF and treatments currently in development, including those in late stages of testing. It profiles key companies and universities researching new CHF therapies and analyzes products at different stages of development. The report aims to help identify emerging treatments and players to inform strategic decision-making around mergers, acquisitions and competitive strategies. It is available for purchase at prices ranging from $2000 to $6000 depending on the license. Contact information is provided to request a sample or related reports on other drug pipelines.
AstraZeneca plc: Company Analysis
AstraZeneca plc: Company AnalysisReportsnReportsThis report examines AstraZeneca's historical performance and forecasts sales and strategy over the next six years. It analyzes AstraZeneca's sales by product, therapy area, geography, and other categories, with 1-6 year forecasts for key drugs. The report finds that AstraZeneca is reorganizing its R&D in challenging times and will see fastest growth in endocrinology due to its diabetes partnership with Bristol-Myers Squibb. However, the company faces significant exposure to drug patent expiries in major markets. The 35-page report is available for $5700 and contains strategic analysis of AstraZeneca as well as financial and operating performance data tables and figures.
Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Rose088Aarkstore.com has released a market research report on cholangiocellular hepatoma detailing the therapeutic pipeline as of H2 2012. The report includes insights into late-stage and discontinued projects, profiles of key players, and various stages of product development from discovery to registration. Additional features encompass drug profiles, combination therapies, and the latest industry news related to cholangiocellular hepatoma.
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Rose088The document provides an overview of the pipeline of treatments for emphysema that are currently under development by companies and universities, including both late stage and early clinical stage products. It reviews key players involved in developing treatments for emphysema and assesses the pipeline based on factors like molecule type and route of administration. The pipeline includes potential treatments like aerosolized alpha-1 antitrypsin and mesenchymal stromal cells.
Pfizer Inc.: Company Analysis
Pfizer Inc.: Company AnalysisReportsnReportsThis report provides a 40-page analysis of Pfizer Inc. examining its historical and forecast performance in the prescription pharmaceutical sector over the next 6 years. Key points covered in the report include strategic insights into Pfizer's outlook, an analysis of sales forecasts by product and geography, and an evaluation of Pfizer's performance against competitors. The report also analyzes the consequences of Pfizer's restructuring in response to the patent expiry of Lipitor, its top-selling drug, as well as its diversification strategy focused on innovation and generic drugs. Financial analyses from 2005-2017 include operating costs, profit margins, and 1-6 year sales forecasts for Pfizer's major drugs.
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Rose088The document announces a market research report from Aarkstore.com titled "Vaxon Biotech – Product Pipeline Review – 2012". The report provides data on Vaxon Biotech's research and development focus, including their current developmental pipeline with latest updates. It also includes information on discontinued and dormant projects. The report scope covers Vaxon Biotech's overview, review of their current human therapeutic pipeline, and coverage of pipeline molecules in various stages of drug development across different therapy areas.
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088This document summarizes a market research report from Global Markets Direct about Incyte Corporation's product pipeline as of 2012. It provides an overview of Incyte's research areas and pipeline of drug candidates, including those in late-stage development and clinical trials. Key information is given about Incyte's business and locations. The full report contains additional details on pipeline candidates like mechanisms of action, development progress updates, and discontinued projects. It also includes tables, figures and references to related reports available from the publisher.
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012Rose088The document announces a market research report from Global Markets Direct titled "S.L.A. Pharma AG - Product Pipeline Review - 2012". The report provides an overview and analysis of S.L.A. Pharma AG's research and development pipeline, including their focus on various therapy areas and current developmental stages of pipeline molecules across different regions. It includes a snapshot of S.L.A. Pharma AG, their key information and facts, as well as details of the report's scope, contents, pipeline products at different stages of development, and drug profiles.
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088This document summarizes a market research report on Actelion Ltd's product pipeline as of 2012. The report provides an overview of Actelion's research areas and pipeline of drugs in development, including those in Phase I, II, and III clinical trials. It also profiles several of Actelion's lead pipeline candidates, describing their purpose, mechanisms of action, and development progress. The full report contains additional details on Actelion's pipeline such as tables, figures, and individual drug profiles.
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088The document announces a market research report on United Therapeutics Corporation's product pipeline from 2012. The report provides data on United Therapeutics' research and development focus, including their current developmental pipeline, completed and discontinued projects. It describes United Therapeutics' pipeline across various therapy areas, and includes details on pipeline molecules in different development stages globally.
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088The document announces the availability of a market research report on the Astrocytoma therapeutic pipeline from Global Markets Direct. The report provides an overview and details on drug candidates in development for Astrocytoma, including those from companies and universities. It covers products from discovery to registration stages and key players involved. Sample pages of the report can be requested by email.
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Rose088The document summarizes a market research report from Global Market Direct on Reata Pharmaceuticals, Inc.'s product pipeline and research focus. It provides an overview of Reata's current pipeline and development programs in key therapeutic areas such as autoimmune diseases, central nervous system diseases, and respiratory diseases. The summary also lists Reata's pipeline drugs and development stages from pre-clinical to phase III, including Bardoxolone Methyl and RTA 403.
Hi tech pharmacal co., inc. (hitk) - financial and strategic swot analysis re...
Hi tech pharmacal co., inc. (hitk) - financial and strategic swot analysis re...raja1233Hi-Tech Pharmacal Co., Inc. is a pharmaceutical company that develops, manufactures, and markets generic prescription drugs, over-the-counter products, and nutritional supplements. It provides a broad range of products for various diseases and conditions. The company supplies its products to major retail pharmacies, distributors, and government agencies. A SWOT analysis of Hi-Tech Pharmacal found that it has strengths in its diversified product portfolio and large customer base, but weaknesses in competition from larger generic drug companies. Opportunities for growth include expanding its over-the-counter product lines, while threats include increased regulatory scrutiny and pricing pressures.
IQ4I Research published a report on Drug Discovery Outsourcing (DDO) Global M...
IQ4I Research published a report on Drug Discovery Outsourcing (DDO) Global M...Vinay Shiva PrasadThis 203-slide report analyzes the global drug discovery outsourcing market, forecasting it to be worth $25 billion by 2025. It provides an in-depth look at major players in the field such as Advinus and Wuxi Apptec, examining their business models, capabilities, finances, and therapeutic areas of focus. In addition, the report evaluates CRO business trends, key metrics, R&D spending among pharmaceutical companies, and competitive strategies used in the drug discovery outsourcing market.
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Rose088The document announces a market research report from Global Markets Direct about the product pipeline of ViroStatics, srl. The report provides data on ViroStatics' research and development focus, including information on current developmental pipeline with updates on discontinued or dormant projects. It also includes a brief overview of ViroStatics, profiles of its clinical and early-stage pipeline products, and details on therapy areas and development progress.
Evaluation of Caprolactam Production Processes
Evaluation of Caprolactam Production ProcessesIntratec SolutionsThe document discusses caprolactam, an organic compound primarily used in producing nylon-6 fibers and plastics, detailing various production pathways and economic comparisons across different regions. It outlines the methodology employed by Intratec in analyzing production costs and technological aspects, emphasizing the importance of thorough research and data collection. Additionally, it highlights the availability of professional reports that assist businesses in assessing capital investment options and R&D opportunities in the chemical industry.
Clinical sas course syllabus
Clinical sas course syllabusSoftlogic SystemsThe document outlines the syllabus for a Clinical SAS course focusing on drug discovery and development processes. The syllabus covers an introduction to clinical trials including their phases and regulations, preparing and analyzing clinical trial data using SAS, generating tables, listings and graphs from clinical data, and performing statistical analyses. Students will learn how to clean, categorize and summarize clinical data, create analysis datasets, report adverse events, and obtain descriptive and inferential statistics to analyze efficacy, safety and time-to-event data. The course aims to provide skills relevant for clinical data management roles in the pharmaceutical industry.
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Rose088The document summarizes a market research report from Global Markets Direct on Proteo, Inc.'s product pipeline as of 2012. It provides an overview of Proteo's business and research areas such as respiratory diseases and organ transplantation. The summary also outlines Proteo's pipeline of drug candidates at different stages of development targeting conditions like COPD, pulmonary hypertension, cardiac infarction, cystic fibrosis, and organ transplantation. Tables and figures in the report provide additional details on Proteo's pipeline and clinical stage and early stage drug candidates.
Evaluation of Hydrogen Chloride Production Processes
Evaluation of Hydrogen Chloride Production ProcessesIntratec SolutionsThe document discusses hydrogen chloride (HCl) production pathways, emphasizing its importance in the chemical industry and detailing various manufacturing methods, including economic comparisons of each pathway. It outlines the comprehensive analysis provided in Intratec's reports, which include information on production costs, capital investments, and historical data. Additionally, Intratec is presented as a reputable research firm that supports companies with insights into chemical market trends and process economics.
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Rose088The document announces a market research report from Global Markets Direct on Nabriva Therapeutics AG's product pipeline as of 2012. The report provides an overview of Nabriva's research areas and developmental pipeline, including projects in clinical and pre-clinical stages. It describes two of Nabriva's lead candidates, BC-3781 and BC-7013, and their mechanisms of action and development progress. The document provides links to purchase the full report and other related pharmaceutical pipeline reviews.
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Rose088The document announces a market research report on Versartis, Inc.'s product pipeline in 2012 from Global Markets Direct. It provides an overview of Versartis' research focus and developmental pipeline at the time, including drug candidates in various stages of clinical trials for conditions like endocrine/metabolic disorders and cancer. The report also details four of Versartis' lead pipeline drugs - VRS-317, VRS-808, VRS-826, and VRS-859 + AMX-808 - and their descriptions, mechanisms of action, and development progress. Tables of contents and figures are included, as well as links to purchase the full report and other similar reports from Global Markets Direct.
India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeRose088The document provides information on a report titled "India Wellness Industry Outlook 2016 – Robust Growth in Alternative Therapy and Nutraceuticals Market". The 123-page report can be purchased for $900 in PDF format, $1200 in hard copy format, or $1650 for an enterprise license. It provides an analysis of the Indian wellness industry market size and segmentation, including categories like fitness, spa services, alternative therapies, cosmetics, and nutraceuticals. The wellness industry in India grew by 16.9% in 2011, particularly among urban residents aged 25-49. The report also covers industry trends, projections, and the market for specific segments like fitness and slimming.
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016Rose088The document summarizes a report on the India Waste Management and Recycling Market Outlook from 2006-2016. The 110-page report provides an analysis of the waste industry in India, focusing on municipal solid waste, industrial hazardous waste, e-waste, and bio medical waste. It details the market size and segmentation of the waste management sector in India. Key topics covered include market sizes and projections, regulations, trends, and the competitive landscape of major players. The report analyzes factors influencing industry growth and provides future projections for waste industry segments in India.
More Related Content
What's hot (20)
AstraZeneca plc: Company Analysis
AstraZeneca plc: Company AnalysisReportsnReportsThis report examines AstraZeneca's historical performance and forecasts sales and strategy over the next six years. It analyzes AstraZeneca's sales by product, therapy area, geography, and other categories, with 1-6 year forecasts for key drugs. The report finds that AstraZeneca is reorganizing its R&D in challenging times and will see fastest growth in endocrinology due to its diabetes partnership with Bristol-Myers Squibb. However, the company faces significant exposure to drug patent expiries in major markets. The 35-page report is available for $5700 and contains strategic analysis of AstraZeneca as well as financial and operating performance data tables and figures.
Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Rose088Aarkstore.com has released a market research report on cholangiocellular hepatoma detailing the therapeutic pipeline as of H2 2012. The report includes insights into late-stage and discontinued projects, profiles of key players, and various stages of product development from discovery to registration. Additional features encompass drug profiles, combination therapies, and the latest industry news related to cholangiocellular hepatoma.
Emphysema – pipeline review, h1 2012
Emphysema – pipeline review, h1 2012Rose088The document provides an overview of the pipeline of treatments for emphysema that are currently under development by companies and universities, including both late stage and early clinical stage products. It reviews key players involved in developing treatments for emphysema and assesses the pipeline based on factors like molecule type and route of administration. The pipeline includes potential treatments like aerosolized alpha-1 antitrypsin and mesenchymal stromal cells.
Pfizer Inc.: Company Analysis
Pfizer Inc.: Company AnalysisReportsnReportsThis report provides a 40-page analysis of Pfizer Inc. examining its historical and forecast performance in the prescription pharmaceutical sector over the next 6 years. Key points covered in the report include strategic insights into Pfizer's outlook, an analysis of sales forecasts by product and geography, and an evaluation of Pfizer's performance against competitors. The report also analyzes the consequences of Pfizer's restructuring in response to the patent expiry of Lipitor, its top-selling drug, as well as its diversification strategy focused on innovation and generic drugs. Financial analyses from 2005-2017 include operating costs, profit margins, and 1-6 year sales forecasts for Pfizer's major drugs.
Vaxon biotech – product pipeline review – 2012
Vaxon biotech – product pipeline review – 2012Rose088The document announces a market research report from Aarkstore.com titled "Vaxon Biotech – Product Pipeline Review – 2012". The report provides data on Vaxon Biotech's research and development focus, including their current developmental pipeline with latest updates. It also includes information on discontinued and dormant projects. The report scope covers Vaxon Biotech's overview, review of their current human therapeutic pipeline, and coverage of pipeline molecules in various stages of drug development across different therapy areas.
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088This document summarizes a market research report from Global Markets Direct about Incyte Corporation's product pipeline as of 2012. It provides an overview of Incyte's research areas and pipeline of drug candidates, including those in late-stage development and clinical trials. Key information is given about Incyte's business and locations. The full report contains additional details on pipeline candidates like mechanisms of action, development progress updates, and discontinued projects. It also includes tables, figures and references to related reports available from the publisher.
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012Rose088The document announces a market research report from Global Markets Direct titled "S.L.A. Pharma AG - Product Pipeline Review - 2012". The report provides an overview and analysis of S.L.A. Pharma AG's research and development pipeline, including their focus on various therapy areas and current developmental stages of pipeline molecules across different regions. It includes a snapshot of S.L.A. Pharma AG, their key information and facts, as well as details of the report's scope, contents, pipeline products at different stages of development, and drug profiles.
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088This document summarizes a market research report on Actelion Ltd's product pipeline as of 2012. The report provides an overview of Actelion's research areas and pipeline of drugs in development, including those in Phase I, II, and III clinical trials. It also profiles several of Actelion's lead pipeline candidates, describing their purpose, mechanisms of action, and development progress. The full report contains additional details on Actelion's pipeline such as tables, figures, and individual drug profiles.
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088The document announces a market research report on United Therapeutics Corporation's product pipeline from 2012. The report provides data on United Therapeutics' research and development focus, including their current developmental pipeline, completed and discontinued projects. It describes United Therapeutics' pipeline across various therapy areas, and includes details on pipeline molecules in different development stages globally.
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088The document announces the availability of a market research report on the Astrocytoma therapeutic pipeline from Global Markets Direct. The report provides an overview and details on drug candidates in development for Astrocytoma, including those from companies and universities. It covers products from discovery to registration stages and key players involved. Sample pages of the report can be requested by email.
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Rose088The document summarizes a market research report from Global Market Direct on Reata Pharmaceuticals, Inc.'s product pipeline and research focus. It provides an overview of Reata's current pipeline and development programs in key therapeutic areas such as autoimmune diseases, central nervous system diseases, and respiratory diseases. The summary also lists Reata's pipeline drugs and development stages from pre-clinical to phase III, including Bardoxolone Methyl and RTA 403.
Hi tech pharmacal co., inc. (hitk) - financial and strategic swot analysis re...
Hi tech pharmacal co., inc. (hitk) - financial and strategic swot analysis re...raja1233Hi-Tech Pharmacal Co., Inc. is a pharmaceutical company that develops, manufactures, and markets generic prescription drugs, over-the-counter products, and nutritional supplements. It provides a broad range of products for various diseases and conditions. The company supplies its products to major retail pharmacies, distributors, and government agencies. A SWOT analysis of Hi-Tech Pharmacal found that it has strengths in its diversified product portfolio and large customer base, but weaknesses in competition from larger generic drug companies. Opportunities for growth include expanding its over-the-counter product lines, while threats include increased regulatory scrutiny and pricing pressures.
IQ4I Research published a report on Drug Discovery Outsourcing (DDO) Global M...
IQ4I Research published a report on Drug Discovery Outsourcing (DDO) Global M...Vinay Shiva PrasadThis 203-slide report analyzes the global drug discovery outsourcing market, forecasting it to be worth $25 billion by 2025. It provides an in-depth look at major players in the field such as Advinus and Wuxi Apptec, examining their business models, capabilities, finances, and therapeutic areas of focus. In addition, the report evaluates CRO business trends, key metrics, R&D spending among pharmaceutical companies, and competitive strategies used in the drug discovery outsourcing market.
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Rose088The document announces a market research report from Global Markets Direct about the product pipeline of ViroStatics, srl. The report provides data on ViroStatics' research and development focus, including information on current developmental pipeline with updates on discontinued or dormant projects. It also includes a brief overview of ViroStatics, profiles of its clinical and early-stage pipeline products, and details on therapy areas and development progress.
Evaluation of Caprolactam Production Processes
Evaluation of Caprolactam Production ProcessesIntratec SolutionsThe document discusses caprolactam, an organic compound primarily used in producing nylon-6 fibers and plastics, detailing various production pathways and economic comparisons across different regions. It outlines the methodology employed by Intratec in analyzing production costs and technological aspects, emphasizing the importance of thorough research and data collection. Additionally, it highlights the availability of professional reports that assist businesses in assessing capital investment options and R&D opportunities in the chemical industry.
Clinical sas course syllabus
Clinical sas course syllabusSoftlogic SystemsThe document outlines the syllabus for a Clinical SAS course focusing on drug discovery and development processes. The syllabus covers an introduction to clinical trials including their phases and regulations, preparing and analyzing clinical trial data using SAS, generating tables, listings and graphs from clinical data, and performing statistical analyses. Students will learn how to clean, categorize and summarize clinical data, create analysis datasets, report adverse events, and obtain descriptive and inferential statistics to analyze efficacy, safety and time-to-event data. The course aims to provide skills relevant for clinical data management roles in the pharmaceutical industry.
Proteo, inc. – product pipeline review – 2012
Proteo, inc. – product pipeline review – 2012Rose088The document summarizes a market research report from Global Markets Direct on Proteo, Inc.'s product pipeline as of 2012. It provides an overview of Proteo's business and research areas such as respiratory diseases and organ transplantation. The summary also outlines Proteo's pipeline of drug candidates at different stages of development targeting conditions like COPD, pulmonary hypertension, cardiac infarction, cystic fibrosis, and organ transplantation. Tables and figures in the report provide additional details on Proteo's pipeline and clinical stage and early stage drug candidates.
Evaluation of Hydrogen Chloride Production Processes
Evaluation of Hydrogen Chloride Production ProcessesIntratec SolutionsThe document discusses hydrogen chloride (HCl) production pathways, emphasizing its importance in the chemical industry and detailing various manufacturing methods, including economic comparisons of each pathway. It outlines the comprehensive analysis provided in Intratec's reports, which include information on production costs, capital investments, and historical data. Additionally, Intratec is presented as a reputable research firm that supports companies with insights into chemical market trends and process economics.
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Rose088The document announces a market research report from Global Markets Direct on Nabriva Therapeutics AG's product pipeline as of 2012. The report provides an overview of Nabriva's research areas and developmental pipeline, including projects in clinical and pre-clinical stages. It describes two of Nabriva's lead candidates, BC-3781 and BC-7013, and their mechanisms of action and development progress. The document provides links to purchase the full report and other related pharmaceutical pipeline reviews.
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Rose088The document announces a market research report on Versartis, Inc.'s product pipeline in 2012 from Global Markets Direct. It provides an overview of Versartis' research focus and developmental pipeline at the time, including drug candidates in various stages of clinical trials for conditions like endocrine/metabolic disorders and cancer. The report also details four of Versartis' lead pipeline drugs - VRS-317, VRS-808, VRS-826, and VRS-859 + AMX-808 - and their descriptions, mechanisms of action, and development progress. Tables of contents and figures are included, as well as links to purchase the full report and other similar reports from Global Markets Direct.
Cholangiocellular hepatoma – pipeline review, h2 2012
Cholangiocellular hepatoma – pipeline review, h2 2012Rose088
Incyte corporation – product pipeline review – 2012
Incyte corporation – product pipeline review – 2012Rose088
S.l.a. pharma ag – product pipeline review – 2012
S.l.a. pharma ag – product pipeline review – 2012Rose088
United therapeutics corporation – product pipeline review – 2012
United therapeutics corporation – product pipeline review – 2012Rose088
Reata pharmaceuticals, inc. – product pipeline review – 2012
Reata pharmaceuticals, inc. – product pipeline review – 2012Rose088
Hi tech pharmacal co., inc. (hitk) - financial and strategic swot analysis re...
Hi tech pharmacal co., inc. (hitk) - financial and strategic swot analysis re...raja1233
IQ4I Research published a report on Drug Discovery Outsourcing (DDO) Global M...
IQ4I Research published a report on Drug Discovery Outsourcing (DDO) Global M...Vinay Shiva Prasad
Viro statics, srl – product pipeline review – 2012
Viro statics, srl – product pipeline review – 2012Rose088
Evaluation of Caprolactam Production Processes
Evaluation of Caprolactam Production ProcessesIntratec Solutions
Evaluation of Hydrogen Chloride Production Processes
Evaluation of Hydrogen Chloride Production ProcessesIntratec Solutions
Nabriva therapeutics ag – product pipeline review – 2012
Nabriva therapeutics ag – product pipeline review – 2012Rose088
Versartis, inc. – product pipeline review – 2012
Versartis, inc. – product pipeline review – 2012Rose088
More from Rose088 (20)
India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeRose088The document provides information on a report titled "India Wellness Industry Outlook 2016 – Robust Growth in Alternative Therapy and Nutraceuticals Market". The 123-page report can be purchased for $900 in PDF format, $1200 in hard copy format, or $1650 for an enterprise license. It provides an analysis of the Indian wellness industry market size and segmentation, including categories like fitness, spa services, alternative therapies, cosmetics, and nutraceuticals. The wellness industry in India grew by 16.9% in 2011, particularly among urban residents aged 25-49. The report also covers industry trends, projections, and the market for specific segments like fitness and slimming.
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016Rose088The document summarizes a report on the India Waste Management and Recycling Market Outlook from 2006-2016. The 110-page report provides an analysis of the waste industry in India, focusing on municipal solid waste, industrial hazardous waste, e-waste, and bio medical waste. It details the market size and segmentation of the waste management sector in India. Key topics covered include market sizes and projections, regulations, trends, and the competitive landscape of major players. The report analyzes factors influencing industry growth and provides future projections for waste industry segments in India.
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Rose088This document summarizes a 106-page report on the pipeline of therapeutics under development for acute renal failure (ARF)/acute kidney injury. The report provides an overview of the therapeutic pipeline as of the second half of 2012, including details on late-stage, mid-clinical stage, early clinical stage, and pre-clinical products. It reviews key players and universities involved in developing treatments for ARF/acute kidney injury and allows identification of emerging companies. The report can be purchased for various license fees or a sample may be requested.
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionRose088This document summarizes a report from GBI Research about downstream processing in biopharmaceuticals. It discusses the adoption of disposable technologies at larger economies of scale to optimize production efficiency and cost-effectiveness. The report provides an overview of the biopharmaceutical and contract manufacturing industries as well as the downstream processing and reagent markets. It also includes market data, forecasts, profiles of key players, and an analysis of drivers and restraints. The report aims to help readers develop market strategies and understand factors shaping the industries.
Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsRose088The document summarizes a market research report on the Chinese markets for industrial lubricants. It examines China's economic trends, industry development, supply and demand for industrial lubricants in China. The report provides historical data from 2001 to 2011 and forecasts through 2016 and 2021. It profiles major lubricant producers in China and analyzes the industrial lubricants industry capacity, market share, technology development and major end-users. The full report is available for 50% off at $2000 and contains sections on business environment, industry assessments, and production and demand for various industrial lubricants.
Mumbai
MumbaiRose088This document summarizes a book about national security in Mumbai. It includes 18 chapters covering various sectors like transport, power, telecom, and others. It discusses security requirements and challenges for each sector. The book aims to assess the implications of security technologies and develop an effective system to address emerging threats. It also includes security requirements for Indian states, union territories, and some other countries.
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088This document summarizes a market research report on the product pipeline of Zydus Cadila Healthcare Limited. The report provides details on Zydus Cadila's research areas and developmental pipeline, including current projects in various stages of development across different therapy areas. It also lists several of Zydus Cadila's pipeline candidates, including their descriptions and development progress. Contact information is provided for requesting a sample of the full market research report.
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088The document summarizes a market research report on ZIOPHARM Oncology, Inc.'s product pipeline as of 2012. It provides an overview of ZIOPHARM's research areas and developmental pipeline, including projects in various stages of development across different therapy areas. The report also includes snapshots of key pipeline candidates such as Ad-IL-12 and DC-IL-12, along with their descriptions, mechanisms of action, and research progress. Tables of contents and figures from the full report are listed as well.
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088The document summarizes a market research report from Global Markets Direct about the product pipeline of TopoTarget A/S, a pharmaceutical company. The report provides details on TopoTarget's current developmental pipeline, including projects in clinical trials and pre-clinical research across various therapy areas. It also profiles several of TopoTarget's key pipeline drugs and combination treatment modalities in development, including their descriptions, mechanisms of action, and research progress. Contact information is provided to request a sample of the full report or for questions.
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088This document summarizes a market research report about MacroGenics, Inc.'s product pipeline as of 2012. It provides an overview of MacroGenics' research areas, pipeline of products in development across various therapy areas and stages of the drug development process. It also includes brief profiles of some of MacroGenics' key pipeline products in development, such as DART for autoimmune disorders, DART mAbs, and monoclonal antibodies. The full report contains additional details on MacroGenics' pipeline like lists of tables and figures as well as related reports that can be purchased.
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088This document summarizes a market research report on YM BioSciences Inc.'s product pipeline as of 2012. It provides an overview of YM BioSciences' business and focus on key therapeutic areas. The report also details YM's pipeline of candidates in various stages of clinical development, including Phase III, Phase II and Phase I trials, as well as combination treatment modalities. It profiles several of YM's lead pipeline candidates and outlines their mechanisms of action and development progress. Contact information is provided to request a sample of the full report or for additional related pharmaceutical reports.
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Rose088This document summarizes a market research report on Ipsen Inc.'s product pipeline in 2012. The report provides an overview of Ipsen's research areas and pipeline of drugs in development, including those in Phase III clinical trials. It also lists Ipsen's locations and subsidiaries. The document encourages requesting a sample of the full market research report or searching for similar reports on pharmaceutical pipelines and healthcare topics through the Aarkstore website.
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088This document summarizes a market research report on MethylGene Inc's product pipeline as of 2012. The report provides details on MethylGene's research areas and pipeline of drug candidates at various stages of clinical trials. It describes several of MethylGene's lead drug candidates, including their mechanisms of action and development progress. Tables of contents and figures are included listing the report's contents. Contact information is provided to request a sample or purchase the full report.
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088This document summarizes a market research report on MerLion Pharmaceuticals Pte Ltd's product pipeline as of 2012. The report provides an overview of MerLion's research areas and developmental pipeline, including both current and discontinued/dormant projects. It describes the various stages of drug development for molecules across MerLion's portfolio in therapeutic areas such as anti-virulence, antibiotics, and anti-fungals. Tables and figures in the report provide additional details on MerLion's clinical and early-stage pipeline products. Contact information is provided for inquiries about purchasing the full report.
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088This document summarizes a market research report on Glenmark Pharmaceuticals Ltd's product pipeline as of 2012. The report provides details on Glenmark's research areas and pipeline of drug candidates at various stages of development, including 4 drugs in late-stage Phase III trials and several others in early-stage pre-clinical testing. Tables of contents and figures are included listing the pipeline drugs and studies. Contact information is provided to request a sample or related reports on pharmaceutical company pipelines and products.
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088This document summarizes a market research report from Global Markets Direct about Geron Corporation's product pipeline as of 2012. The report provides an overview of Geron's research areas and pipeline of drug candidates, including those in clinical trials for cancer and other conditions. It describes five of Geron's lead candidates in development - GRN1005, GRN163L, a combination of GRN163L with paclitaxel and bevacizumab, a combination of GRN163L with paclitaxel and carboplatin, and GRN510. Details provided on each candidate include its description, mechanism of action, and development progress.
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088The document summarizes a market research report on ImmunoGen, Inc.'s product pipeline as of 2012. It provides an overview of ImmunoGen's research areas and developmental pipeline, including current projects in various stages of development for cancer treatments. The report is compiled using data from ImmunoGen's corporate resources as well as third party sources, and includes profiles for several of ImmunoGen's lead pipeline candidates with details on their descriptions, mechanisms of action, and research progress. Links are also provided to other related product pipeline reports available.
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088The document summarizes a market research report on the product pipeline of 7TM Pharma A/S, a pharmaceutical company. It provides details on 7TM Pharma's current pipeline, including developmental stages of pipeline products across various therapy areas. Key pipeline molecules discussed include a drug for metabolic disorders, PAD program, TM30339, TM30510, and TM38837. The report also analyzes 7TM Pharma's research and development focus and pipeline.
Emerging power markets in south east asia
Emerging power markets in south east asiaRose088The document announces the availability of a new market research report from GBI Research titled "Emerging Power Markets in South-East Asia, Middle East and Africa to 2020 - Government’s Restructuring Reforms Encouraging Private Participation will Enhance Price Competition and Efficiency". The report provides an analysis of the power markets, regulatory frameworks, and forecasts for installed capacity and generation in 7 countries in those regions through 2020. It also includes details on consumption, tables of contents, and links to other related reports.
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchRose088The document summarizes a market research report from GBI Research about how cloud computing can optimize data management in pharmaceutical research and development, particularly for next-generation DNA sequencing and clinical trials data; it provides an overview of cloud computing technologies and models as well as applications in the pharmaceutical industry and competitive landscape of major cloud computing providers.
India wellness industry outlook 2016 robust growth in alternative
India wellness industry outlook 2016 robust growth in alternativeRose088
India waste management and recycling market outlook to 2016
India waste management and recycling market outlook to 2016Rose088
Acute renal failure (arf) (acute kidney injury)
Acute renal failure (arf) (acute kidney injury)Rose088
Downstream processing in biopharmaceuticals adoption
Downstream processing in biopharmaceuticals adoptionRose088
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088
Ad
Recently uploaded (12)
Oneworld Energy USA LLC Fraud CEO Mike Minor.pptx
Oneworld Energy USA LLC Fraud CEO Mike Minor.pptxnathaniel leonardOneworld Energy USA LLC CEO Accused in Multi-Jurisdictional Fraud: A Closer Look at Mike Minor
Pathos Communications When Reputation Management Becomes Reputation Destructi...
Pathos Communications When Reputation Management Becomes Reputation Destructi...nathaniel leonardA recent letter from UK-based firm Pathos Communications: When Reputation Management Becomes Reputation Destruction
Air India Plane Crash: Tragedy Strikes Near Ahmedabad
Air India Plane Crash: Tragedy Strikes Near AhmedabadNew India Abroad The Air India Plane Crash on June 12, 2025, shocked the nation and the global Indian community. A Boeing 787-8 Dreamliner, carrying 242 passengers and crew, crashed shortly after taking off from Ahmedabad Airport, on route to London. The aircraft struck a hostel near B.J. Medical College, causing fatalities both onboard and on the ground. Investigations are ongoing, focusing on possible engine failure. One Indian-origin British passenger survived. Families worldwide are mourning this tragic Air India Plane Crash, and New India Abroad continues to provide in-depth coverage on the disaster and its far-reaching impact.
Abdulwahed Abdulazeez- the legacy of a kind leader
Abdulwahed Abdulazeez- the legacy of a kind leadersameerlicht19Some key moments captured during the tenure of Abdulwahed Abdulazeez as the 44th Executive President of ASSON ABU Zaria
EDSA Revolution and Democracy - the Youth and Students in Focus [uploadable]....
EDSA Revolution and Democracy - the Youth and Students in Focus [uploadable]....ssuser0e98111This presentation talks about the EDSA Revolution and Democracy in general and its context with the youth.
Οι χώρες της Ευρώπης με την καλύτερη ποιότητα υδάτων για κολύμβηση – Η θέσητ...
Οι χώρες της Ευρώπης με την καλύτερη ποιότητα υδάτων για κολύμβηση – Η θέσητ...Newsroom8«Εξαιρετικής ποιότητας» το 97% των υδάτων κολύμβησης στην Ελλάδα. Τι αναφέρει έκθεση για την Ευρώπη και τα στοιχεία γιατηχώραμας.
POLITICAL AND RELIGIOUS ASPECTS OF POWER IN INDIA
POLITICAL AND RELIGIOUS ASPECTS OF POWER IN INDIAAnushka SinghDESCRIBES INTERSECTION OF THE POLITICAL AND RELIGIOUS ASPECTS OF POWER IN INDIA
Indian Community Centers – New India Abroad
Indian Community Centers – New India AbroadNew India Abroad New India Abroad highlights the vital role of Indian community centers in uniting the global Indian diaspora. These centers offer cultural programs, language classes, legal support, and social events, helping immigrants stay connected to their roots while integrating abroad. Found in cities like New York, London, and Toronto, Indian community centers foster belonging and cultural pride. New India Abroad proudly showcases their impact, promoting unity, tradition, and support across Indian communities worldwide.
PRESS-RELEASE-WIFE-3.pdfKen Ofori-Atta undergoes successful prostate cancer s...
PRESS-RELEASE-WIFE-3.pdfKen Ofori-Atta undergoes successful prostate cancer s...businessweekghanaKen Ofori-Atta undergoes successful prostate cancer surgery – Wife discloses
Gatwick AG About A Company Shut Down by UK Courts Still Sells Offshore Servic...
Gatwick AG About A Company Shut Down by UK Courts Still Sells Offshore Servic...nathaniel leonardGatwick AG was dissolved by British authorities in 2023. Its website remains active. And former clients say they’ve been misled and defrauded.
Vijay Rupani Biography: Early Life, Education, and Political Career
Vijay Rupani Biography: Early Life, Education, and Political CareerVoterMoodExplore the biography of Vijay Rupani—his early life, academic background, and rise in Indian politics through the ranks of the BJP.
Connecting the Indian Community Abroad – New India Abroad
Connecting the Indian Community Abroad – New India AbroadNew India Abroad New India Abroad is dedicated to strengthening the global Indian community by sharing inspiring stories, news, and achievements of Indians living overseas. We highlight their contributions across business, culture, science, and public service. Whether it's entrepreneurship in the U.S. or academic success in Europe, New India Abroad brings their journeys to light. Our mission is to foster unity, pride, and a shared identity among the vibrant Indian community abroad, helping them stay informed and connected.
Oneworld Energy USA LLC Fraud CEO Mike Minor.pptx
Oneworld Energy USA LLC Fraud CEO Mike Minor.pptxnathaniel leonard
Pathos Communications When Reputation Management Becomes Reputation Destructi...
Pathos Communications When Reputation Management Becomes Reputation Destructi...nathaniel leonard
Air India Plane Crash: Tragedy Strikes Near Ahmedabad
Air India Plane Crash: Tragedy Strikes Near AhmedabadNew India Abroad
Abdulwahed Abdulazeez- the legacy of a kind leader
Abdulwahed Abdulazeez- the legacy of a kind leadersameerlicht19
EDSA Revolution and Democracy - the Youth and Students in Focus [uploadable]....
EDSA Revolution and Democracy - the Youth and Students in Focus [uploadable]....ssuser0e98111
Οι χώρες της Ευρώπης με την καλύτερη ποιότητα υδάτων για κολύμβηση – Η θέσητ...
Οι χώρες της Ευρώπης με την καλύτερη ποιότητα υδάτων για κολύμβηση – Η θέσητ...Newsroom8
POLITICAL AND RELIGIOUS ASPECTS OF POWER IN INDIA
POLITICAL AND RELIGIOUS ASPECTS OF POWER IN INDIAAnushka Singh
Indian Community Centers – New India Abroad
Indian Community Centers – New India AbroadNew India Abroad
PRESS-RELEASE-WIFE-3.pdfKen Ofori-Atta undergoes successful prostate cancer s...
PRESS-RELEASE-WIFE-3.pdfKen Ofori-Atta undergoes successful prostate cancer s...businessweekghana
Gatwick AG About A Company Shut Down by UK Courts Still Sells Offshore Servic...
Gatwick AG About A Company Shut Down by UK Courts Still Sells Offshore Servic...nathaniel leonard
Vijay Rupani Biography: Early Life, Education, and Political Career
Vijay Rupani Biography: Early Life, Education, and Political CareerVoterMood
Connecting the Indian Community Abroad – New India Abroad
Connecting the Indian Community Abroad – New India AbroadNew India Abroad
Ad
Hereditary angioedema (hae) – pipeline review, h2 2012
- 1. You can also request for sample page of above mention reports on sample@aarkstore.com
- 2. Pages : 82 PDF - $ 2000 | Site Licence - $ 4000 $ | Enterprise License - $ 6000 | 20% Off on above 1000$ Reports 25% off on purchase of 2 reports and 30% on purchase of 3 or more reports. Discount till 31st Dec. 2012.
- 3. Summary Global Markets Direct’s, Hereditary Angioedema (HAE) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hereditary Angioedema (HAE), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hereditary Angioedema (HAE). Hereditary Angioedema (HAE) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
- 4. Scope - A snapshot of the global therapeutic scenario for Hereditary Angioedema (HAE). - A review of the Hereditary Angioedema (HAE) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Hereditary Angioedema (HAE). - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- 5. Table of Contents : List of Tables 4 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Hereditary Angioedema (HAE) Overview 7 Therapeutics Development 8 An Overview of Pipeline Products for Hereditary Angioedema (HAE) 8 Hereditary Angioedema (HAE) Therapeutics under Development by Companies 10 Late Stage Products 11 Comparative Analysis 11 Mid Clinical Stage Products 12 Comparative Analysis 12 Early Clinical Stage Products 13 Comparative Analysis 13 Pre-Clinical Stage Products 14 Comparative Analysis 14 Hereditary Angioedema (HAE) Therapeutics – Products under Development by Companies 15……………….
- 6. Please follow link if you want More Related Reports : Pipeline Review, H2 2012 http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1
- 7. Related Reports: Generalized Seizures – Pipeline Review, H2 2012 Cataract – Pipeline Review, H2 2012 Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H2 2012 Thrombocythaemia Myelofibrosis – Pipeline Review, H2 2012 Erosive Oral Lichen Planus – Pipeline Review, H2 2012 Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012 Blepharitis – Pipeline Review, H2 2012 Hypoparathyroidism – Pipeline Review, H2 2012 Lyme Disease – Pipeline Review, H2 2012 Optic Nerve Injury – Pipeline Review, H2 2012 Auto Inflammatory Disease – Pipeline Review, H2 2012
- 8. For More details about above & other Reports plz contact : Lavanya Aarkstore.com Contact: Marketing team Mob.No.918149852585 Email: enquiry@aarkstore.com , discount@aarkstore.com URL: http://www.aarkstore.com http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstore